By The Hill Staff - 11/11/11 05:00 AM EST
Rapid innovation in genetic testing is producing dramatic changes in care for
such cancers as leukemia, colon cancer, and breast cancer. Join us for a discussion, Thursday, November 17, 2011, about
the impact of this innovation on outcomes, side effects and utilization of resources. We will be livestreaming the event at 8:30 a.m.
Featuring remarks by:
Congressman Michael Burgess MD (R-Tex.), Vice Chair of the House Energy and Commerce Health Subcommittee
Congressman Charles Gonzalez (D-Tex.), Member of the House Energy and Commerce Health Subcommittee
Mara Bloom, Executive Director, Cancer Center, Massachusetts General Hospital
Marc Grodman, MD, President, CEO, Chairman, Bio-Reference Laboratories, Inc.
Bill McGivney, PhD, CEO, National Comprehensive Cancer Network
Simon Tripp, Senior Director, Battelle Memorial Institute
MATERIALS FROM THE BREAKFAST